CLINICAL_TRIALS
trial_result
· 2011-01-24
Clinical Trial Update: A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease [Phase 4]
Summary
A Phase 4 study of cisapride in patients with gastroesophageal reflux disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Gastroesophageal Reflux | Phase 4 | Status: TERMINATED